Avara Pharmaceutical Services’ facility in Liscate, Italy, which provides sterile manufacturing, fill-finish, and packaging services for supply to European, U.S., Canadian, and Latin American markets, recently hosted the U.S. FDA as part of a Pre-Approval Inspection for a new client’s product to be manufactured in the small volume parenterals department. In addition, a routine GMP inspection for the lyophilization department was also conducted. FDA recommended the renewal of the facility license...